9.67

6.39% -0.66

After Hours: 9.67

Leonabio Inc (LONA)

Overview News Price History Discussions Forecast

Leonabio Inc stock is traded at $9.67, with a volume of 88,635. It is down -6.39% in the last 24 hours and up +16.09% over the past month. LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Previous Close:

$10.33

Open:

$10.49

24h Volume:

88,635

Relative Volume:

1.51

Market Cap:

$90.84M

Revenue:

Net Income/Loss:

$-129.41M

P/E Ratio:

-0.4014

EPS:

-24.0922

Net Cash Flow:

$-51.97M

1W Performance:

-4.16%

1M Performance:

+16.09%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$9.56

$10.49

1-Week Range:

$9.17

$11.44

52-Week Range:

$4.21

$14.21

Leonabio Inc Stock (LONA) Company Profile

Name

Leonabio Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

(425) 620-8501

Address

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Employee

Twitter

Next Earnings Date

2026-05-08

Latest SEC Filings

LONA's Discussions on Twitter

Compare LONA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LONA Leonabio Inc	9.67	97.03M	0	-129.41M	-51.97M	-24.09
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Leonabio Inc Stock (LONA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Initiated	Cantor Fitzgerald	Overweight
Feb-19-26	Upgrade	Mizuho	Neutral → Outperform
Sep-19-24	Downgrade	Mizuho	Outperform → Neutral
Sep-04-24	Downgrade	BTIG Research	Buy → Neutral
Sep-04-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-04-24	Downgrade	Rodman & Renshaw	Buy → Neutral
Aug-19-24	Initiated	Rodman & Renshaw	Buy
Oct-17-22	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Jul-07-22	Initiated	Mizuho	Buy
Jun-23-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-23-22	Downgrade	Jefferies	Buy → Hold
Jun-23-22	Downgrade	Stifel	Buy → Hold
May-10-22	Initiated	BTIG Research	Buy
Apr-21-22	Initiated	Berenberg	Buy
Dec-15-21	Initiated	Goldman	Neutral
Oct-13-20	Initiated	Goldman	Buy
Oct-13-20	Initiated	JMP Securities	Mkt Outperform
Oct-13-20	Initiated	Jefferies	Buy
Oct-13-20	Initiated	Stifel	Buy

View All

Leonabio Inc Stock (LONA) Latest News

May 25, 2026